Cannabis-Induced Hypersensitivity Pneumonitis: A Case Report by Miles, Matthew J., DO & Zirlinger, Andres, MD





Matthew J. Miles DO
Lehigh Valley Health Network, Matthew.Miles@lvhn.org
Andres Zirlinger MD
Lehigh Valley Health Network, Andres.Zirlinger@lvhn.org
Follow this and additional works at: http://scholarlyworks.lvhn.org/medicine
Part of the Medical Sciences Commons
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.
Published In/Presented At
Miles, M., Zirlinger, A. (2015, May 20). Cannabis-Induced Hypersensitivity Pneumonitis: A Case Report. Poster presented at: American
Thoracic Society International Conference, Denver, CO.
Lehigh Valley Health Network, Allentown, Pennsylvania
Matthew J. Miles, DO and Andres Zirlinger, MD
Cannabis-Induced Hypersensitivity Pneumonitis: A Case Report
Case Report
A 64 year old male presented with worsening dyspnea, five pound weight loss, night 
sweats and dry cough for two weeks. He denied chest pain, fever or sick contacts. The 
patient was a former tobacco smoker, quitting 50 years prior to admission. He had a 
history of asthma with a recent admission for presumed asthma exacerbation which 
responded well to a short course of oral steroids. On admission his oxygen saturation 
was 92% while breathing room air; physical exam was essentially normal except 
for bibasilar crackles. White cell count, liver and kidney function were normal. The 
initial chest X-ray showed bibasilar interstitial infiltrates (Figure 1) so he was started 
on antibiotics for presumed hospital acquired pneumonia. One day after admission 
he developed hypoxic respiratory failure secondary to acute respiratory distress 
syndrome (ARDS) which required invasive mechanical ventilation. A CT scan of the 
chest revealed bilateral ground-glass opacities (Figure 2). A bronchoscopy did not reveal 
any abnormalities of the airways. Thus, he underwent a video-assisted thoracoscopic 
biopsy of the lung. The cultures and stains from the biopsy were negative for organisms; 
pathology revealed patchy areas of consolidation presented by a pattern of organizing 
pneumonia mixed with multiple, poorly formed non-caseating granulomas consistent 
with hypersensitivity pneumonitis. 
The patient was started on corticosteroids daily and was extubated two days after 
treatment. After extubation, the patient’s daughter mentioned that the patient had been 
regularly smoking a significant amount of cannabis, but did not want anyone to find out. 
The patient’s symptoms completely resolved after 8 weeks of corticosteroid therapy 
and cannabis cessation. A confirmation CT scan showed resolution of bilateral ground-
glass opacities after 10 weeks of medical therapy (Figure 3). The patient continued to be 
asymptomatic 22 weeks after cessation of steroids and cannabis use. 
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Figure 1: Initial chest X-ray showing bibasilar 
interstitial infiltrates.



















Figure 3: CT of Chest showing resolution 
of bilateral ground-glass opacities after 10 
weeks.
Figure 4: Chest X-ray showing improvement 
of bibasilar interstitial infiltrates after 12 weeks.
Introduction
Hypersensitivity pneumonitis is a complex syndrome caused by an inflammatory 
mediated reaction in the lungs due to an external antigen.1,2 The more common antigens 
include molds, fungal spores, bacteria and yeasts.3 There have been few publications 
recommending diagnostic criteria, however, they have not been validated.2 Diagnosing 
hypersensitivity pneumonitis relies on several clinic features including: patient’s 
history (cough, wheezing, weight loss, smoking history), physical exam (fever, crackles 
on pulmonary exam and digital clubbing) identifying microbiologic and environment 
exposures, bronchoalveolar lavage (BAL) (lymphocytosis), computerized tomography (CT) 
scan (ground-glass opacifications), histopathology (non-caseating granulomas).3 
Hypersensitivity pneumonitis can be treated with systemic corticosteroids and removal 
of the offending antigen.1-3 However, even with treatment, patients with hypersensitivity 
pneumonitis can develop chronic lung conditions such as pulmonary fibrosis and 
emphysema.2 
Discussion
•  The patient’s history, physical exam findings, CT scan and biopsy are all supportive of the diagnosis hypersensitivity pneumonitis.
•  The clinical improvement and the resolution of CT findings after oral steroids and cannabis cessation confirms the diagnosis. 
•  Multiple studies citing that cannabis can be contaminated with fungus and lead to diseases such as invasive and allergic bronchopulmonary aspergillosis. Bacteria linked 
to hypersensitivity pneumonitis have also been recovered from cannabis samples. Unfortunately, a sample of the patient’s suspected contaminated cannabis was not able 
to be obtained. The patient lives in a suburban area and denied any other exposures known to cause hypersensitivity pneumonitis.
•  Specific antibodies were not tested for since hypersensitivity cannot be ruled in or out based on antibody testing.
•  To our knowledge, this is the first case report of cannabis smoking induced hypersensitivity pneumonitis.
•  Cannabis use is increasing in the United States with an estimated 54% of the population using cannabis at least once before the age of 21.
•  It is important to consider hypersensitivity pneumonitis in patients that smoke cannabis and present with dyspnea and cough.
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